(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
(Address of principal executive offices) | (Zip Code) |
Title of each class | Trading symbol(s) | Name of each exchange on which registered | ||||||
Emerging growth company | |||||||||||
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. | ☐ |
Exhibit No. | Description | ||||
104* | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
BRIGHTHOUSE FINANCIAL, INC. | ||||||||
By: | /s/ Lynn A. Dumais | |||||||
Name: | Lynn A. Dumais | |||||||
Title: | Chief Accounting Officer |
PUBLIC RELATIONS Brighthouse Financial, Inc. 11225 N. Community House Rd. Charlotte, NC 28277 |
PUBLIC RELATIONS Brighthouse Financial, Inc. 11225 N. Community House Rd. Charlotte, NC 28277 |
As of or For the Three Months Ended | ||||||||||||||||||||||||||
March 31, 2020 | March 31, 2019 | |||||||||||||||||||||||||
Total | Per share | Total | Per share | |||||||||||||||||||||||
Net income (loss) available to shareholders (1) | $4,950 | $47.11 | $(737) | $(6.31) | ||||||||||||||||||||||
Adjusted earnings (1) | $211 | $2.01 | $232 | $1.98 | ||||||||||||||||||||||
Adjusted earnings, less notable items (1) | $273 | $2.60 | $259 | $2.21 | ||||||||||||||||||||||
Weighted average common shares outstanding - diluted (1) | 105,093,515 | N/A | 117,229,854 | N/A | ||||||||||||||||||||||
Book value | $19,962 | $198.62 | $14,587 | $125.55 | ||||||||||||||||||||||
Book value, excluding AOCI | $17,315 | $172.28 | $12,917 | $111.18 | ||||||||||||||||||||||
Ending common shares outstanding | 100,502,488 | N/A | 116,182,687 | N/A | ||||||||||||||||||||||
(1) Per share amounts are on a diluted basis and may not recalculate due to rounding. For loss periods, dilutive shares were not included in the calculation as inclusion of such shares would have an anti-dilutive effect. See Non-GAAP and Other Financial Disclosures discussion in this news release. |
PUBLIC RELATIONS Brighthouse Financial, Inc. 11225 N. Community House Rd. Charlotte, NC 28277 |
For the Three Months Ended | ||||||||||||||||||||
ADJUSTED EARNINGS | March 31, 2020 | December 31, 2019 | March 31, 2019 | |||||||||||||||||
Annuities | $316 | $265 | $295 | |||||||||||||||||
Life | $11 | $75 | $25 | |||||||||||||||||
Run-off (1) | $(70) | $6 | $(36) | |||||||||||||||||
Corporate & Other (1) | $(46) | $(64) | $(52) | |||||||||||||||||
(1) The company uses the term “adjusted loss” throughout this news release to refer to negative adjusted earnings values. |
For the Three Months Ended | ||||||||||||||||||||
March 31, 2020 | December 31, 2019 | March 31, 2019 | ||||||||||||||||||
Annuities (1) | $1,969 | $1,871 | $1,707 | |||||||||||||||||
Life | $16 | $12 | $1 | |||||||||||||||||
(1) Annuities sales include sales of a fixed indexed annuity product sold by Massachusetts Mutual Life Insurance Company, representing 90% of gross sales of that product. Sales of this product were $208 million for the first quarter of 2020, $261 million for the fourth quarter of 2019, and $281 million for the first quarter of 2019. |
PUBLIC RELATIONS Brighthouse Financial, Inc. 11225 N. Community House Rd. Charlotte, NC 28277 |
For the Three Months Ended | ||||||||||||||||||||
March 31, 2020 | December 31, 2019 | March 31, 2019 | ||||||||||||||||||
Net investment income | $916 | $898 | $811 | |||||||||||||||||
Adjusted net investment income | $920 | $904 | $811 |
PUBLIC RELATIONS Brighthouse Financial, Inc. 11225 N. Community House Rd. Charlotte, NC 28277 |
As of | ||||||||||||||||||||
March 31, 2020 (1) | December 31, 2019 | March 31, 2019 | ||||||||||||||||||
Statutory combined total adjusted capital | $7.2 | $9.7 | $6.3 | |||||||||||||||||
(1) Reflects preliminary statutory results as of March 31, 2020. | ||||||||||||||||||||
PUBLIC RELATIONS Brighthouse Financial, Inc. 11225 N. Community House Rd. Charlotte, NC 28277 |
FOR INVESTORS David Rosenbaum (980) 949-3326 david.rosenbaum@brighthousefinancial.com | FOR MEDIA Deon Roberts (980) 949-3071 deon.roberts@brighthousefinancial.com |
PUBLIC RELATIONS Brighthouse Financial, Inc. 11225 N. Community House Rd. Charlotte, NC 28277 |
PUBLIC RELATIONS Brighthouse Financial, Inc. 11225 N. Community House Rd. Charlotte, NC 28277 |
Non-GAAP financial measures: | Most directly comparable GAAP financial measures: | ||||
adjusted earnings | net income (loss) available to shareholders (1) | ||||
adjusted earnings, less notable items | net income (loss) available to shareholders (1) | ||||
adjusted revenues | revenues | ||||
adjusted expenses | expenses | ||||
adjusted earnings per common share | earnings per common share, diluted (1) | ||||
adjusted earnings per common share, less notable items | earnings per common share, diluted (1) | ||||
adjusted return on common equity | return on common equity (2) | ||||
adjusted return on common equity, less notable items | return on common equity (2) | ||||
adjusted net investment income | net investment income | ||||
__________________ | |||||
(1) Brighthouse uses net income (loss) available to shareholders to refer to net income (loss) available to Brighthouse Financial, Inc.'s common shareholders, and earnings per common share, diluted to refer to net income (loss) available to shareholders per common share. | |||||
(2) Brighthouse uses return on common equity to refer to return on Brighthouse Financial, Inc.'s common stockholders' equity. |
PUBLIC RELATIONS Brighthouse Financial, Inc. 11225 N. Community House Rd. Charlotte, NC 28277 |
PUBLIC RELATIONS Brighthouse Financial, Inc. 11225 N. Community House Rd. Charlotte, NC 28277 |
PUBLIC RELATIONS Brighthouse Financial, Inc. 11225 N. Community House Rd. Charlotte, NC 28277 |
PUBLIC RELATIONS Brighthouse Financial, Inc. 11225 N. Community House Rd. Charlotte, NC 28277 |
For the Three Months Ended | ||||||||||||||||||||
Revenues | March 31, 2020 | December 31, 2019 | March 31, 2019 | |||||||||||||||||
Premiums | $198 | $209 | $227 | |||||||||||||||||
Universal life and investment-type product policy fees | 886 | 950 | 875 | |||||||||||||||||
Net investment income | 916 | 898 | 811 | |||||||||||||||||
Other revenues | 102 | 107 | 92 | |||||||||||||||||
Revenues before NIGL and NDGL | 2,102 | 2,164 | 2,005 | |||||||||||||||||
Net investment gains (losses) | (19) | 33 | (11) | |||||||||||||||||
Net derivative gains (losses) | 6,902 | (1,891) | (1,303) | |||||||||||||||||
Total revenues | $8,985 | $306 | $691 | |||||||||||||||||
Expenses | ||||||||||||||||||||
Interest credited to policyholder account balances | $259 | $268 | $258 | |||||||||||||||||
Policyholder benefits and claims | 1,187 | 734 | 772 | |||||||||||||||||
Amortization of DAC and VOBA | 770 | 9 | 22 | |||||||||||||||||
Interest expense on debt | 47 | 47 | 47 | |||||||||||||||||
Other expenses | 470 | 620 | 545 | |||||||||||||||||
Total expenses | 2,733 | 1,678 | 1,644 | |||||||||||||||||
Income (loss) before provision for income tax | 6,252 | (1,372) | (953) | |||||||||||||||||
Provision for income tax expense (benefit) | 1,293 | (303) | (218) | |||||||||||||||||
Net income (loss) | 4,959 | (1,069) | (735) | |||||||||||||||||
Less: Net income (loss) attributable to noncontrolling interests | 2 | 1 | 2 | |||||||||||||||||
Net income (loss) attributable to Brighthouse Financial, Inc. | 4,957 | (1,070) | (737) | |||||||||||||||||
Less: Preferred stock dividends | 7 | 7 | — | |||||||||||||||||
Net income (loss) available to Brighthouse Financial, Inc.’s common shareholders | $4,950 | $(1,077) | $(737) |
PUBLIC RELATIONS Brighthouse Financial, Inc. 11225 N. Community House Rd. Charlotte, NC 28277 |
As of | ||||||||||||||||||||
ASSETS | March 31, 2020 | December 31, 2019 | March 31, 2019 | |||||||||||||||||
Investments: | ||||||||||||||||||||
Fixed maturity securities available-for-sale | $71,302 | $71,036 | $64,847 | |||||||||||||||||
Equity securities | 122 | 147 | 150 | |||||||||||||||||
Mortgage loans, net | 15,547 | 15,753 | 14,504 | |||||||||||||||||
Policy loans | 1,250 | 1,292 | 1,385 | |||||||||||||||||
Limited partnerships and limited liability companies | 2,505 | 2,380 | 2,253 | |||||||||||||||||
Short-term investments | 4,348 | 1,958 | 799 | |||||||||||||||||
Other invested assets | 9,658 | 3,216 | 2,302 | |||||||||||||||||
Total investments | 104,732 | 95,782 | 86,240 | |||||||||||||||||
Cash and cash equivalents | 8,930 | 2,877 | 3,864 | |||||||||||||||||
Accrued investment income | 868 | 684 | 791 | |||||||||||||||||
Reinsurance recoverables | 14,220 | 13,990 | 13,098 | |||||||||||||||||
Premiums and other receivables | 774 | 770 | 928 | |||||||||||||||||
DAC and VOBA | 4,862 | 5,448 | 5,680 | |||||||||||||||||
Current income tax recoverable | 9 | 17 | — | |||||||||||||||||
Other assets | 550 | 584 | 618 | |||||||||||||||||
Separate account assets | 89,008 | 107,107 | 105,211 | |||||||||||||||||
Total assets | $223,953 | $227,259 | $216,430 | |||||||||||||||||
LIABILITIES AND EQUITY | ||||||||||||||||||||
Liabilities | ||||||||||||||||||||
Future policy benefits | $40,653 | $39,686 | $37,157 | |||||||||||||||||
Policyholder account balances | 47,288 | 45,771 | 41,177 | |||||||||||||||||
Other policy-related balances | 3,169 | 3,111 | 3,005 | |||||||||||||||||
Payables for collateral under securities loaned and other transactions | 10,988 | 4,391 | 3,990 | |||||||||||||||||
Long-term debt | 4,365 | 4,365 | 4,364 | |||||||||||||||||
Current income tax payable | — | — | 19 | |||||||||||||||||
Deferred income tax liability | 2,482 | 1,355 | 1,005 | |||||||||||||||||
Other liabilities | 5,561 | 5,236 | 5,438 | |||||||||||||||||
Separate account liabilities | 89,008 | 107,107 | 105,211 | |||||||||||||||||
Total liabilities | 203,514 | 211,022 | 201,366 | |||||||||||||||||
Equity | ||||||||||||||||||||
Preferred Stock, at par value | — | — | — | |||||||||||||||||
Common stock, at par value | 1 | 1 | 1 | |||||||||||||||||
Additional paid-in capital | 12,911 | 12,908 | 12,889 | |||||||||||||||||
Retained earnings (deficit) | 5,521 | 585 | 609 | |||||||||||||||||
Treasury stock | (706) | (562) | (170) | |||||||||||||||||
Accumulated other comprehensive income (loss) | 2,647 | 3,240 | 1,670 | |||||||||||||||||
Total Brighthouse Financial, Inc.’s stockholders’ equity | 20,374 | 16,172 | 14,999 | |||||||||||||||||
Noncontrolling interests | 65 | 65 | 65 | |||||||||||||||||
Total equity | 20,439 | 16,237 | 15,064 | |||||||||||||||||
Total liabilities and equity | $223,953 | $227,259 | $216,430 |
PUBLIC RELATIONS Brighthouse Financial, Inc. 11225 N. Community House Rd. Charlotte, NC 28277 |
For the Three Months Ended | For the Year Ended | |||||||||||||||||||||||||
ADJUSTED EARNINGS, LESS NOTABLE ITEMS | March 31, 2020 | December 31, 2019 | March 31, 2019 | |||||||||||||||||||||||
Net income (loss) available to shareholders | $4,950 | $(1,077) | $(737) | |||||||||||||||||||||||
Less: Net investment gains (losses) | (19) | 33 | (11) | |||||||||||||||||||||||
Less: Net derivative gains (losses), excluding investment hedge adjustments | 6,898 | (1,897) | (1,303) | |||||||||||||||||||||||
Less: GMIB Fees and GMIB Costs | (166) | 34 | 35 | |||||||||||||||||||||||
Less: Amortization of DAC and VOBA | (671) | 93 | 75 | |||||||||||||||||||||||
Less: Market value adjustments and other | (43) | 17 | (23) | |||||||||||||||||||||||
Less: Provision for income tax (expense) benefit on reconciling adjustments | (1,260) | 361 | 258 | |||||||||||||||||||||||
Adjusted earnings | 211 | 282 | 232 | |||||||||||||||||||||||
Less: Notable items | (62) | 17 | (27) | |||||||||||||||||||||||
Adjusted earnings, less notable items | $273 | $265 | $259 | |||||||||||||||||||||||
ADJUSTED EARNINGS, LESS NOTABLE ITEMS PER COMMON SHARE (1) | ||||||||||||||||||||||||||
Net income (loss) available to shareholders per common share | $47.11 | $(10.02) | $(6.31) | |||||||||||||||||||||||
Less: Net investment gains (losses) | (0.18) | 0.31 | (0.09) | |||||||||||||||||||||||
Less: Net derivative gains (losses), excluding investment hedge adjustments | 65.64 | (17.65) | (11.16) | |||||||||||||||||||||||
Less: GMIB Fees and GMIB Costs | (1.58) | 0.32 | 0.30 | |||||||||||||||||||||||
Less: Amortization of DAC and VOBA | (6.38) | 0.87 | 0.64 | |||||||||||||||||||||||
Less: Market value adjustments and other | (0.41) | 0.16 | (0.20) | |||||||||||||||||||||||
Less: Provision for income tax (expense) benefit on reconciling adjustments | (11.99) | 3.36 | 2.21 | |||||||||||||||||||||||
Less: Impact of inclusion of dilutive shares | — | 0.01 | 0.01 | |||||||||||||||||||||||
Adjusted earnings per common share | 2.01 | 2.61 | 1.98 | |||||||||||||||||||||||
Less: Notable items | (0.59) | 0.16 | (0.23) | |||||||||||||||||||||||
Adjusted earnings, less notable items per common share | $2.60 | $2.46 | $2.21 | |||||||||||||||||||||||
(1) Per share calculations are on a diluted basis and may not recalculate or foot due to rounding. For loss periods, dilutive shares were not included in the calculation as inclusion of such shares would have an anti-dilutive effect. See Non-GAAP and Other Financial Disclosures discussion in this news release. |
PUBLIC RELATIONS Brighthouse Financial, Inc. 11225 N. Community House Rd. Charlotte, NC 28277 |
For the Three Months Ended | For the Three Months Ended | |||||||||||||||||||||||||
March 31, 2020 | December 31, 2019 | March 31, 2019 | ||||||||||||||||||||||||
Net investment income | $916 | $898 | $811 | |||||||||||||||||||||||
Less: Investment hedge adjustments | (4) | (6) | — | |||||||||||||||||||||||
Adjusted net investment income | $920 | $904 | $811 |
For the Three Months Ended | For the Three Months Ended | |||||||||||||||||||||||||
NOTABLE ITEMS IMPACTING ADJUSTED EARNINGS | March 31, 2020 | December 31, 2019 | March 31, 2019 | |||||||||||||||||||||||
Actuarial items and other insurance adjustments | $48 | $(42) | $— | |||||||||||||||||||||||
Establishment costs | 14 | 25 | 27 | |||||||||||||||||||||||
Total notable items (1) | $62 | $(17) | $27 | |||||||||||||||||||||||
NOTABLE ITEMS BY SEGMENT AND CORPORATE & OTHER | ||||||||||||||||||||||||||
Annuities | $— | $(42) | $— | |||||||||||||||||||||||
Life | — | — | — | |||||||||||||||||||||||
Run-off | 48 | — | — | |||||||||||||||||||||||
Corporate & Other | 14 | 25 | 27 | |||||||||||||||||||||||
Total notable items (1) | $62 | $(17) | $27 | |||||||||||||||||||||||
(1) Notable items reflect the negative (positive) after-tax impact to adjusted earnings of certain unanticipated items and events, as well as certain items and events that were anticipated, such as establishment costs. The presentation of notable items is intended to help investors better understand our results and to evaluate and forecast those results. |
Table of Contents | Financial Results | ||||||||||
Earnings and Select Metrics from Business Segments and Corporate & Other | |||||||||||
Other Information | |||||||||||
Appendix | |||||||||||
A-2 | |||||||||||
A-6 | |||||||||||
A-7 | Reconciliation of Net Income (Loss) Available to Shareholders to Adjusted Earnings and Adjusted Earnings, Less Notable Items, and Reconciliation of Net Income (Loss) Available to Shareholders per Common Share to Adjusted Earnings per Common Share and Adjusted Earnings, Less Notable Items per Common Share | ||||||||||
A-8 | |||||||||||
A-9 | |||||||||||
A-10 | |||||||||||
Financial Supplement | 1 |
As of or For the Three Months Ended | |||||||||||||||||||||||||||||||||||
Financial Results and Metrics (1) | March 31, 2020 | December 31, 2019 | September 30, 2019 | June 30, 2019 | March 31, 2019 | ||||||||||||||||||||||||||||||
Net income (loss) available to shareholders | $4,950 | $(1,077) | $676 | $377 | $(737) | ||||||||||||||||||||||||||||||
Adjusted earnings | $211 | $282 | $(169) | $254 | $232 | ||||||||||||||||||||||||||||||
Adjusted earnings, less notable items (2) | $273 | $265 | $260 | $296 | $259 | ||||||||||||||||||||||||||||||
Total corporate expenses (3) | $214 | $283 | $248 | $242 | $225 | ||||||||||||||||||||||||||||||
Combined total adjusted capital (4) | $7,200 | $9,694 | $8,406 | $6,897 | $6,314 | ||||||||||||||||||||||||||||||
Combined risk-based capital ratio (4), (5) | 515% - 535% | 552% | N/A | N/A | N/A | ||||||||||||||||||||||||||||||
Stockholders' Equity | |||||||||||||||||||||||||||||||||||
Brighthouse Financial, Inc.’s stockholders’ equity | $20,374 | $16,172 | $17,695 | $16,276 | $14,999 | ||||||||||||||||||||||||||||||
Less: Preferred stock, net | 412 | 412 | 412 | 412 | 412 | ||||||||||||||||||||||||||||||
Brighthouse Financial, Inc.’s common stockholders’ equity, including AOCI | $19,962 | $15,760 | $17,283 | $15,864 | $14,587 | ||||||||||||||||||||||||||||||
Less: AOCI | 2,647 | 3,240 | 3,567 | 2,702 | 1,670 | ||||||||||||||||||||||||||||||
Brighthouse Financial, Inc.’s common stockholders’ equity, excluding AOCI | $17,315 | $12,520 | $13,716 | $13,162 | $12,917 | ||||||||||||||||||||||||||||||
Return on Common Equity (1) | |||||||||||||||||||||||||||||||||||
Return on common equity | 29.5% | (4.9)% | 11.7% | 5.7% | 1.4% | ||||||||||||||||||||||||||||||
Return on common equity, excluding AOCI | 35.4% | (5.8)% | 13.4% | 6.3% | 1.5% | ||||||||||||||||||||||||||||||
Adjusted return on common equity | 4.2% | 4.5% | 3.8% | 7.3% | 6.5% | ||||||||||||||||||||||||||||||
Earnings Per Common Share, Diluted (1), (6) | |||||||||||||||||||||||||||||||||||
Net income (loss) available to shareholders per common share | $47.11 | $(10.02) | $6.06 | $3.27 | $(6.31) | ||||||||||||||||||||||||||||||
Adjusted earnings per common share | $2.01 | $2.61 | $(1.52) | $2.19 | $1.98 | ||||||||||||||||||||||||||||||
Adjusted earnings, less notable items per common share | $2.60 | $2.46 | $2.33 | $2.56 | $2.21 | ||||||||||||||||||||||||||||||
Weighted average common shares outstanding | 105,093,515 | 107,840,324 | 111,527,480 | 115,536,654 | 117,229,854 | ||||||||||||||||||||||||||||||
Book Value Per Common Share | |||||||||||||||||||||||||||||||||||
Book value per common share (1) | $198.62 | $148.64 | $158.18 | $140.83 | $125.55 | ||||||||||||||||||||||||||||||
Book value per common share, excluding AOCI (1) | $172.28 | $118.08 | $125.53 | $116.85 | $111.18 | ||||||||||||||||||||||||||||||
Ending common shares outstanding | 100,502,488 | 106,027,301 | 109,264,305 | 112,644,952 | 116,182,687 | ||||||||||||||||||||||||||||||
(1) See definitions for Non-GAAP and Other Financial Disclosures in the Appendix beginning on page A-2. | |||||||||||||||||||||||||||||||||||
(2) See additional information regarding notable items on page 17. | |||||||||||||||||||||||||||||||||||
(3) Includes functional department expenses, public company expenses, certain investment expenses, retirement funding and incentive compensation; and excludes establishment costs. | |||||||||||||||||||||||||||||||||||
(4) Reflects preliminary statutory results for the three months ended March 31, 2020. See additional information on page 5. | |||||||||||||||||||||||||||||||||||
(5) RBC ratios prior to the implementation of variable annuity capital reform are not presented. | |||||||||||||||||||||||||||||||||||
(6) For loss periods, dilutive shares were not included in the calculation of net income (loss) available to shareholders per common share or adjusted earnings per common share as inclusion of such shares would have an anti-dilutive effect. |
Financial Supplement | 2 |
For the Three Months Ended | For the Three Months Ended | |||||||||||||||||||||||||||||||||||||||||||
Revenues | March 31, 2020 | December 31, 2019 | September 30, 2019 | June 30, 2019 | March 31, 2019 | March 31, 2020 | March 31, 2019 | |||||||||||||||||||||||||||||||||||||
Premiums | $198 | $209 | $214 | $232 | $227 | $198 | $227 | |||||||||||||||||||||||||||||||||||||
Universal life and investment-type product policy fees | 886 | 950 | 867 | 888 | 875 | 886 | 875 | |||||||||||||||||||||||||||||||||||||
Net investment income | 916 | 898 | 928 | 942 | 811 | 916 | 811 | |||||||||||||||||||||||||||||||||||||
Other revenues | 102 | 107 | 94 | 96 | 92 | 102 | 92 | |||||||||||||||||||||||||||||||||||||
Revenues before NIGL and NDGL | 2,102 | 2,164 | 2,103 | 2,158 | 2,005 | 2,102 | 2,005 | |||||||||||||||||||||||||||||||||||||
Net investment gains (losses) | (19) | 33 | 27 | 63 | (11) | (19) | (11) | |||||||||||||||||||||||||||||||||||||
Net derivative gains (losses) | 6,902 | (1,891) | 1,057 | 149 | (1,303) | 6,902 | (1,303) | |||||||||||||||||||||||||||||||||||||
Total revenues | $8,985 | $306 | $3,187 | $2,370 | $691 | $8,985 | $691 | |||||||||||||||||||||||||||||||||||||
Expenses | ||||||||||||||||||||||||||||||||||||||||||||
Interest credited to policyholder account balances | $259 | $268 | $272 | $265 | $258 | $259 | $258 | |||||||||||||||||||||||||||||||||||||
Policyholder benefits and claims | 1,187 | 734 | 1,319 | 845 | 772 | 1,187 | 772 | |||||||||||||||||||||||||||||||||||||
Amortization of DAC and VOBA | 770 | 9 | 181 | 170 | 22 | 770 | 22 | |||||||||||||||||||||||||||||||||||||
Interest expense on debt | 47 | 47 | 49 | 48 | 47 | 47 | 47 | |||||||||||||||||||||||||||||||||||||
Other expenses | 470 | 620 | 562 | 573 | 545 | 470 | 545 | |||||||||||||||||||||||||||||||||||||
Total expenses | 2,733 | 1,678 | 2,383 | 1,901 | 1,644 | 2,733 | 1,644 | |||||||||||||||||||||||||||||||||||||
Income (loss) before provision for income tax | 6,252 | (1,372) | 804 | 469 | (953) | 6,252 | (953) | |||||||||||||||||||||||||||||||||||||
Provision for income tax expense (benefit) | 1,293 | (303) | 119 | 85 | (218) | 1,293 | (218) | |||||||||||||||||||||||||||||||||||||
Net income (loss) | 4,959 | (1,069) | 685 | 384 | (735) | 4,959 | (735) | |||||||||||||||||||||||||||||||||||||
Less: Net income (loss) attributable to noncontrolling interests | 2 | 1 | 2 | — | 2 | 2 | 2 | |||||||||||||||||||||||||||||||||||||
Net income (loss) attributable to Brighthouse Financial, Inc. | 4,957 | (1,070) | 683 | 384 | (737) | 4,957 | (737) | |||||||||||||||||||||||||||||||||||||
Less: Preferred stock dividends | 7 | 7 | 7 | 7 | — | 7 | — | |||||||||||||||||||||||||||||||||||||
Net income (loss) available to Brighthouse Financial, Inc.’s common shareholders | $4,950 | $(1,077) | $676 | $377 | $(737) | $4,950 | $(737) |
Financial Supplement | 3 |
As of | ||||||||||||||||||||||||||||||||
ASSETS | March 31, 2020 | December 31, 2019 | September 30, 2019 | June 30, 2019 | March 31, 2019 | |||||||||||||||||||||||||||
Investments: | ||||||||||||||||||||||||||||||||
Fixed maturity securities available-for-sale | $71,302 | $71,036 | $70,723 | $67,211 | $64,847 | |||||||||||||||||||||||||||
Equity securities | 122 | 147 | 148 | 153 | 150 | |||||||||||||||||||||||||||
Mortgage loans, net | 15,547 | 15,753 | 15,359 | 15,078 | 14,504 | |||||||||||||||||||||||||||
Policy loans | 1,250 | 1,292 | 1,332 | 1,342 | 1,385 | |||||||||||||||||||||||||||
Limited partnerships and limited liability companies | 2,505 | 2,380 | 2,353 | 2,296 | 2,253 | |||||||||||||||||||||||||||
Short-term investments | 4,348 | 1,958 | 1,985 | 793 | 799 | |||||||||||||||||||||||||||
Other invested assets | 9,658 | 3,216 | 4,734 | 3,064 | 2,302 | |||||||||||||||||||||||||||
Total investments | 104,732 | 95,782 | 96,634 | 89,937 | 86,240 | |||||||||||||||||||||||||||
Cash and cash equivalents | 8,930 | 2,877 | 4,289 | 3,981 | 3,864 | |||||||||||||||||||||||||||
Accrued investment income | 868 | 684 | 732 | 747 | 791 | |||||||||||||||||||||||||||
Reinsurance recoverables | 14,220 | 13,990 | 13,412 | 13,366 | 13,098 | |||||||||||||||||||||||||||
Premiums and other receivables | 774 | 770 | 973 | 865 | 928 | |||||||||||||||||||||||||||
DAC and VOBA | 4,862 | 5,448 | 5,317 | 5,492 | 5,680 | |||||||||||||||||||||||||||
Current income tax recoverable | 9 | 17 | 14 | — | — | |||||||||||||||||||||||||||
Other assets | 550 | 584 | 577 | 610 | 618 | |||||||||||||||||||||||||||
Separate account assets | 89,008 | 107,107 | 103,928 | 106,214 | 105,211 | |||||||||||||||||||||||||||
Total assets | $223,953 | $227,259 | $225,876 | $221,212 | $216,430 | |||||||||||||||||||||||||||
LIABILITIES AND EQUITY | ||||||||||||||||||||||||||||||||
Liabilities | ||||||||||||||||||||||||||||||||
Future policy benefits | $40,653 | $39,686 | $39,846 | $38,280 | $37,157 | |||||||||||||||||||||||||||
Policyholder account balances | 47,288 | 45,771 | 44,919 | 42,941 | 41,177 | |||||||||||||||||||||||||||
Other policy-related balances | 3,169 | 3,111 | 3,079 | 3,041 | 3,005 | |||||||||||||||||||||||||||
Payables for collateral under securities loaned and other transactions | 10,988 | 4,391 | 5,291 | 4,094 | 3,990 | |||||||||||||||||||||||||||
Long-term debt | 4,365 | 4,365 | 4,365 | 4,365 | 4,364 | |||||||||||||||||||||||||||
Current income tax payable | — | — | — | 14 | 19 | |||||||||||||||||||||||||||
Deferred income tax liability | 2,482 | 1,355 | 1,749 | 1,364 | 1,005 | |||||||||||||||||||||||||||
Other liabilities | 5,561 | 5,236 | 4,939 | 4,558 | 5,438 | |||||||||||||||||||||||||||
Separate account liabilities | 89,008 | 107,107 | 103,928 | 106,214 | 105,211 | |||||||||||||||||||||||||||
Total liabilities | 203,514 | 211,022 | 208,116 | 204,871 | 201,366 | |||||||||||||||||||||||||||
Equity | ||||||||||||||||||||||||||||||||
Preferred Stock, at par value | — | — | — | — | — | |||||||||||||||||||||||||||
Common stock, at par value | 1 | 1 | 1 | 1 | 1 | |||||||||||||||||||||||||||
Additional paid-in capital | 12,911 | 12,908 | 12,897 | 12,893 | 12,889 | |||||||||||||||||||||||||||
Retained earnings (deficit) | 5,521 | 585 | 1,662 | 986 | 609 | |||||||||||||||||||||||||||
Treasury stock | (706) | (562) | (432) | (306) | (170) | |||||||||||||||||||||||||||
Accumulated other comprehensive income (loss) | 2,647 | 3,240 | 3,567 | 2,702 | 1,670 | |||||||||||||||||||||||||||
Total Brighthouse Financial, Inc.’s stockholders’ equity | 20,374 | 16,172 | 17,695 | 16,276 | 14,999 | |||||||||||||||||||||||||||
Noncontrolling interests | 65 | 65 | 65 | 65 | 65 | |||||||||||||||||||||||||||
Total equity | 20,439 | 16,237 | 17,760 | 16,341 | 15,064 | |||||||||||||||||||||||||||
Total liabilities and equity | $223,953 | $227,259 | $225,876 | $221,212 | $216,430 |
Financial Supplement | 5 |
For the Three Months Ended March 31, 2020 | ||||||||||||||||||||||||||||||||
Adjusted revenues | Annuities | Life | Run-off | Corporate & Other | Total | |||||||||||||||||||||||||||
Premiums | $35 | $141 | $— | $22 | $198 | |||||||||||||||||||||||||||
Universal life and investment-type product policy fees | 566 | 93 | 162 | — | 821 | |||||||||||||||||||||||||||
Net investment income | 460 | 116 | 324 | 20 | 920 | |||||||||||||||||||||||||||
Other revenues | 90 | 4 | 7 | — | 101 | |||||||||||||||||||||||||||
Total adjusted revenues | $1,151 | $354 | $493 | $42 | $2,040 | |||||||||||||||||||||||||||
Adjusted expenses | ||||||||||||||||||||||||||||||||
Interest credited to policyholder account balances | $155 | $27 | $77 | $— | $259 | |||||||||||||||||||||||||||
Policyholder benefits and claims | 204 | 237 | 454 | 17 | 912 | |||||||||||||||||||||||||||
Amortization of DAC and VOBA | 38 | 58 | — | 3 | 99 | |||||||||||||||||||||||||||
Interest expense on debt | — | — | — | 47 | 47 | |||||||||||||||||||||||||||
Other operating costs | 365 | 19 | 52 | 34 | 470 | |||||||||||||||||||||||||||
Total adjusted expenses | 762 | 341 | 583 | 101 | 1,787 | |||||||||||||||||||||||||||
Adjusted earnings before provision for income tax | 389 | 13 | (90) | (59) | 253 | |||||||||||||||||||||||||||
Provision for income tax expense (benefit) | 73 | 2 | (20) | (22) | 33 | |||||||||||||||||||||||||||
Adjusted earnings after provision for income tax | 316 | 11 | (70) | (37) | 220 | |||||||||||||||||||||||||||
Less: Net income (loss) attributable to noncontrolling interests and preferred stock dividends | — | — | — | 9 | 9 | |||||||||||||||||||||||||||
Adjusted earnings | $316 | $11 | $(70) | $(46) | $211 | |||||||||||||||||||||||||||
For the Three Months Ended March 31, 2019 | ||||||||||||||||||||||||||||||||
Adjusted revenues | Annuities | Life | Run-off | Corporate & Other | Total | |||||||||||||||||||||||||||
Premiums | $58 | $145 | $1 | $23 | $227 | |||||||||||||||||||||||||||
Universal life and investment-type product policy fees | 561 | 58 | 193 | (3) | 809 | |||||||||||||||||||||||||||
Net investment income | 421 | 97 | 276 | 17 | 811 | |||||||||||||||||||||||||||
Other revenues | 77 | 3 | 6 | 6 | 92 | |||||||||||||||||||||||||||
Total adjusted revenues | $1,117 | $303 | $476 | $43 | $1,939 | |||||||||||||||||||||||||||
Adjusted expenses | ||||||||||||||||||||||||||||||||
Interest credited to policyholder account balances | $137 | $25 | $96 | $— | $258 | |||||||||||||||||||||||||||
Policyholder benefits and claims | 143 | 181 | 380 | 14 | 718 | |||||||||||||||||||||||||||
Amortization of DAC and VOBA | 82 | 11 | — | 4 | 97 | |||||||||||||||||||||||||||
Interest expense on debt | — | — | — | 47 | 47 | |||||||||||||||||||||||||||
Other operating costs | 394 | 55 | 46 | 50 | 545 | |||||||||||||||||||||||||||
Total adjusted expenses | 756 | 272 | 522 | 115 | 1,665 | |||||||||||||||||||||||||||
Adjusted earnings before provision for income tax | 361 | 31 | (46) | (72) | 274 | |||||||||||||||||||||||||||
Provision for income tax expense (benefit) | 66 | 6 | (10) | (22) | 40 | |||||||||||||||||||||||||||
Adjusted earnings after provision for income tax | 295 | 25 | (36) | (50) | 234 | |||||||||||||||||||||||||||
Less: Net income (loss) attributable to noncontrolling interests and preferred stock dividends | — | — | — | 2 | 2 | |||||||||||||||||||||||||||
Adjusted earnings | $295 | $25 | $(36) | $(52) | $232 |
Financial Supplement | 6 |
For the Three Months Ended | For the Three Months Ended | |||||||||||||||||||||||||||||||||||||||||||
Adjusted revenues | March 31, 2020 | December 31, 2019 | September 30, 2019 | June 30, 2019 | March 31, 2019 | March 31, 2020 | March 31, 2019 | |||||||||||||||||||||||||||||||||||||
Premiums | $35 | $32 | $48 | $60 | $58 | $35 | $58 | |||||||||||||||||||||||||||||||||||||
Universal life and investment-type product policy fees | 566 | 585 | 596 | 584 | 561 | 566 | 561 | |||||||||||||||||||||||||||||||||||||
Net investment income | 460 | 457 | 461 | 470 | 421 | 460 | 421 | |||||||||||||||||||||||||||||||||||||
Other revenues | 90 | 79 | 79 | 80 | 77 | 90 | 77 | |||||||||||||||||||||||||||||||||||||
Total adjusted revenues | $1,151 | $1,153 | $1,184 | $1,194 | $1,117 | $1,151 | $1,117 | |||||||||||||||||||||||||||||||||||||
Adjusted expenses | ||||||||||||||||||||||||||||||||||||||||||||
Interest credited to policyholder account balances | $155 | $151 | $149 | $147 | $137 | $155 | $137 | |||||||||||||||||||||||||||||||||||||
Policyholder benefits and claims | 204 | 134 | 152 | 180 | 143 | 204 | 143 | |||||||||||||||||||||||||||||||||||||
Amortization of DAC and VOBA | 38 | 95 | 211 | 128 | 82 | 38 | 82 | |||||||||||||||||||||||||||||||||||||
Interest expense on debt | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||
Other operating costs | 365 | 449 | 417 | 416 | 394 | 365 | 394 | |||||||||||||||||||||||||||||||||||||
Total adjusted expenses | 762 | 829 | 929 | 871 | 756 | 762 | 756 | |||||||||||||||||||||||||||||||||||||
Adjusted earnings before provision for income tax | 389 | 324 | 255 | 323 | 361 | 389 | 361 | |||||||||||||||||||||||||||||||||||||
Provision for income tax expense (benefit) | 73 | 59 | 52 | 58 | 66 | 73 | 66 | |||||||||||||||||||||||||||||||||||||
Adjusted earnings | $316 | $265 | $203 | $265 | $295 | $316 | $295 |
Financial Supplement | 7 |
For the Three Months Ended | ||||||||||||||||||||||||||||||||
VARIABLE & SHIELD LEVEL ANNUITIES ACCOUNT VALUE (1) | March 31, 2020 | December 31, 2019 | September 30, 2019 | June 30, 2019 | March 31, 2019 | |||||||||||||||||||||||||||
Account value, beginning of period | $116,426 | $112,707 | $114,041 | $112,247 | $105,089 | |||||||||||||||||||||||||||
Deposits | 1,607 | 1,608 | 1,490 | 1,511 | 1,327 | |||||||||||||||||||||||||||
Withdrawals, surrenders and contract benefits | (2,656) | (2,826) | (2,667) | (2,716) | (2,479) | |||||||||||||||||||||||||||
Net flows (2) | (1,049) | (1,218) | (1,177) | (1,205) | (1,152) | |||||||||||||||||||||||||||
Investment performance (3) | (14,066) | 5,693 | 650 | 3,687 | 8,971 | |||||||||||||||||||||||||||
Policy charges and other | (620) | (756) | (807) | (688) | (661) | |||||||||||||||||||||||||||
Account value, end of period | $100,691 | $116,426 | $112,707 | $114,041 | $112,247 | |||||||||||||||||||||||||||
FIXED ANNUITIES ACCOUNT VALUE (4) | ||||||||||||||||||||||||||||||||
Account value, beginning of period | $13,113 | $13,069 | $12,900 | $12,734 | $12,770 | |||||||||||||||||||||||||||
Deposits | 402 | 314 | 355 | 410 | 416 | |||||||||||||||||||||||||||
Withdrawals, surrenders and contract benefits | (272) | (332) | (250) | (312) | (521) | |||||||||||||||||||||||||||
Net flows (2) | 130 | (18) | 105 | 98 | (105) | |||||||||||||||||||||||||||
Interest credited | 89 | 88 | 92 | 87 | 90 | |||||||||||||||||||||||||||
Other | (19) | (26) | (28) | (19) | (21) | |||||||||||||||||||||||||||
Account value, end of period | $13,313 | $13,113 | $13,069 | $12,900 | $12,734 | |||||||||||||||||||||||||||
INCOME ANNUITIES (1) | ||||||||||||||||||||||||||||||||
Income annuity insurance liabilities | $4,565 | $4,588 | $4,590 | $4,515 | $4,541 | |||||||||||||||||||||||||||
(1) Includes general account and separate account. | ||||||||||||||||||||||||||||||||
(2) Deposits and withdrawals include policy exchanges. | ||||||||||||||||||||||||||||||||
(3) Includes imputed interest on indexed annuities and the interest credited on the general account investment option of variable products. | ||||||||||||||||||||||||||||||||
(4) Includes fixed indexed annuities. |
Financial Supplement | 8 |
For the Three Months Ended | For the Three Months Ended | |||||||||||||||||||||||||||||||||||||||||||
VARIABLE & SHIELD LEVEL ANNUITY SALES | March 31, 2020 | December 31, 2019 | September 30, 2019 | June 30, 2019 | March 31, 2019 | March 31, 2020 | March 31, 2019 | |||||||||||||||||||||||||||||||||||||
Shield Level Annuities (1) | $1,140 | $1,197 | $1,137 | $1,140 | $985 | $1,140 | $985 | |||||||||||||||||||||||||||||||||||||
GMWB/GMAB | 322 | 264 | 223 | 227 | 198 | 322 | 198 | |||||||||||||||||||||||||||||||||||||
GMDB only | 87 | 80 | 72 | 80 | 78 | 87 | 78 | |||||||||||||||||||||||||||||||||||||
GMIB | 19 | 17 | 18 | 26 | 23 | 19 | 23 | |||||||||||||||||||||||||||||||||||||
Total variable & Shield Level annuity sales | $1,568 | $1,558 | $1,450 | $1,473 | $1,284 | $1,568 | $1,284 | |||||||||||||||||||||||||||||||||||||
FIXED ANNUITY SALES | ||||||||||||||||||||||||||||||||||||||||||||
Fixed indexed annuities (2) | $208 | $261 | $296 | $291 | $281 | $208 | $281 | |||||||||||||||||||||||||||||||||||||
Fixed deferred annuities | 191 | 49 | 55 | 114 | 133 | 191 | 133 | |||||||||||||||||||||||||||||||||||||
Single premium immediate annuities | 1 | 3 | 5 | 8 | 6 | 1 | 6 | |||||||||||||||||||||||||||||||||||||
Other fixed annuities | 1 | — | 2 | 4 | 3 | 1 | 3 | |||||||||||||||||||||||||||||||||||||
Total fixed annuity sales | $401 | $313 | $358 | $417 | $423 | $401 | $423 | |||||||||||||||||||||||||||||||||||||
(1) Shield Level Annuities refers to our suite of structured annuities consisting of products marketed under various names. | ||||||||||||||||||||||||||||||||||||||||||||
(2) Represents 90% of gross sales assumed via reinsurance agreements. |
Financial Supplement | 9 |
For the Three Months Ended | For the Three Months Ended | |||||||||||||||||||||||||||||||||||||||||||
Adjusted revenues | March 31, 2020 | December 31, 2019 | September 30, 2019 | June 30, 2019 | March 31, 2019 | March 31, 2020 | March 31, 2019 | |||||||||||||||||||||||||||||||||||||
Premiums | $141 | $154 | $143 | $150 | $145 | $141 | $145 | |||||||||||||||||||||||||||||||||||||
Universal life and investment-type product policy fees | 93 | 109 | 53 | 59 | 58 | 93 | 58 | |||||||||||||||||||||||||||||||||||||
Net investment income | 116 | 106 | 117 | 116 | 97 | 116 | 97 | |||||||||||||||||||||||||||||||||||||
Other revenues | 4 | 6 | 7 | 5 | 3 | 4 | 3 | |||||||||||||||||||||||||||||||||||||
Total adjusted revenues | $354 | $375 | $320 | $330 | $303 | $354 | $303 | |||||||||||||||||||||||||||||||||||||
Adjusted expenses | ||||||||||||||||||||||||||||||||||||||||||||
Interest credited to policyholder account balances | $27 | $26 | $30 | $24 | $25 | $27 | $25 | |||||||||||||||||||||||||||||||||||||
Policyholder benefits and claims | 237 | 190 | 179 | 169 | 181 | 237 | 181 | |||||||||||||||||||||||||||||||||||||
Amortization of DAC and VOBA | 58 | 4 | (31) | 21 | 11 | 58 | 11 | |||||||||||||||||||||||||||||||||||||
Interest expense on debt | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||
Other operating costs | 19 | 61 | 51 | 44 | 55 | 19 | 55 | |||||||||||||||||||||||||||||||||||||
Total adjusted expenses | 341 | 281 | 229 | 258 | 272 | 341 | 272 | |||||||||||||||||||||||||||||||||||||
Adjusted earnings before provision for income tax | 13 | 94 | 91 | 72 | 31 | 13 | 31 | |||||||||||||||||||||||||||||||||||||
Provision for income tax expense (benefit) | 2 | 19 | 18 | 14 | 6 | 2 | 6 | |||||||||||||||||||||||||||||||||||||
Adjusted earnings | $11 | $75 | $73 | $58 | $25 | $11 | $25 |
Financial Supplement | 10 |
For the Three Months Ended | ||||||||||||||||||||||||||||||||
LIFE ACCOUNT VALUE: GENERAL ACCOUNT | March 31, 2020 | December 31, 2019 | September 30, 2019 | June 30, 2019 | March 31, 2019 | |||||||||||||||||||||||||||
Variable universal and universal life account value, beginning of period | $2,682 | $2,699 | $2,707 | $2,727 | $2,747 | |||||||||||||||||||||||||||
Premiums and deposits (1) | 74 | 62 | 62 | 58 | 65 | |||||||||||||||||||||||||||
Surrenders and contract benefits | (33) | (37) | (42) | (49) | (52) | |||||||||||||||||||||||||||
Net flows | 41 | 25 | 20 | 9 | 13 | |||||||||||||||||||||||||||
Net transfers from (to) separate account | 19 | 12 | 17 | 18 | 13 | |||||||||||||||||||||||||||
Interest credited | 25 | 26 | 26 | 26 | 25 | |||||||||||||||||||||||||||
Policy charges and other | (76) | (80) | (71) | (73) | (71) | |||||||||||||||||||||||||||
Variable universal and universal life account value, end of period | $2,691 | $2,682 | $2,699 | $2,707 | $2,727 | |||||||||||||||||||||||||||
LIFE ACCOUNT VALUE: SEPARATE ACCOUNT | ||||||||||||||||||||||||||||||||
Variable universal life account value, beginning of period | $5,493 | $5,200 | $5,269 | $5,138 | $4,679 | |||||||||||||||||||||||||||
Premiums and deposits | 52 | 54 | 54 | 55 | 59 | |||||||||||||||||||||||||||
Surrenders and contract benefits | (65) | (60) | (63) | (63) | (69) | |||||||||||||||||||||||||||
Net flows | (13) | (6) | (9) | (8) | (10) | |||||||||||||||||||||||||||
Investment performance | (928) | 366 | 15 | 212 | 539 | |||||||||||||||||||||||||||
Net transfers from (to) general account | (19) | (12) | (17) | (18) | (15) | |||||||||||||||||||||||||||
Policy charges and other | (55) | (55) | (58) | (55) | (55) | |||||||||||||||||||||||||||
Variable universal life account value, end of period | $4,478 | $5,493 | $5,200 | $5,269 | $5,138 | |||||||||||||||||||||||||||
(1) Includes premiums and sales directed to the general account investment option of variable products. |
Financial Supplement | 11 |
For the Three Months Ended | For the Three Months Ended | |||||||||||||||||||||||||||||||||||||||||||
LIFE SALES | March 31, 2020 | December 31, 2019 | September 30, 2019 | June 30, 2019 | March 31, 2019 | March 31, 2020 | March 31, 2019 | |||||||||||||||||||||||||||||||||||||
Total life sales | $16 | $12 | $8 | $4 | $1 | $16 | $1 |
As of | ||||||||||||||||||||||||||||||||
LIFE INSURANCE IN-FORCE | March 31, 2020 | December 31, 2019 | September 30, 2019 | June 30, 2019 | March 31, 2019 | |||||||||||||||||||||||||||
Whole Life | ||||||||||||||||||||||||||||||||
Life Insurance in-force, before reinsurance | $20,298 | $20,602 | $20,954 | $21,212 | $21,518 | |||||||||||||||||||||||||||
Life Insurance in-force, net of reinsurance | $3,105 | $3,163 | $3,150 | $3,172 | $3,638 | |||||||||||||||||||||||||||
Term Life | ||||||||||||||||||||||||||||||||
Life Insurance in-force, before reinsurance | $402,720 | $409,427 | $415,478 | $421,507 | $427,239 | |||||||||||||||||||||||||||
Life Insurance in-force, net of reinsurance | $309,500 | $314,034 | $317,274 | $321,285 | $324,941 | |||||||||||||||||||||||||||
Universal and Variable Universal Life | ||||||||||||||||||||||||||||||||
Life Insurance in-force, before reinsurance | $53,009 | $54,269 | $54,892 | $55,628 | $56,378 | |||||||||||||||||||||||||||
Life Insurance in-force, net of reinsurance | $39,466 | $40,461 | $38,543 | $39,139 | $39,844 | |||||||||||||||||||||||||||
Financial Supplement | 12 |
For the Three Months Ended | For the Three Months Ended | |||||||||||||||||||||||||||||||||||||||||||
Adjusted revenues | March 31, 2020 | December 31, 2019 | September 30, 2019 | June 30, 2019 | March 31, 2019 | March 31, 2020 | March 31, 2019 | |||||||||||||||||||||||||||||||||||||
Premiums | $— | $1 | $— | $— | $1 | $— | $1 | |||||||||||||||||||||||||||||||||||||
Universal life and investment-type product policy fees | 162 | 191 | 150 | 182 | 193 | 162 | 193 | |||||||||||||||||||||||||||||||||||||
Net investment income | 324 | 323 | 327 | 339 | 276 | 324 | 276 | |||||||||||||||||||||||||||||||||||||
Other revenues | 7 | 7 | 7 | 6 | 6 | 7 | 6 | |||||||||||||||||||||||||||||||||||||
Total adjusted revenues | $493 | $522 | $484 | $527 | $476 | $493 | $476 | |||||||||||||||||||||||||||||||||||||
Adjusted expenses | ||||||||||||||||||||||||||||||||||||||||||||
Interest credited to policyholder account balances | $77 | $91 | $92 | $94 | $96 | $77 | $96 | |||||||||||||||||||||||||||||||||||||
Policyholder benefits and claims | 454 | 371 | 885 | 380 | 380 | 454 | 380 | |||||||||||||||||||||||||||||||||||||
Amortization of DAC and VOBA | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||
Interest expense on debt | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||
Other operating costs | 52 | 53 | 50 | 51 | 46 | 52 | 46 | |||||||||||||||||||||||||||||||||||||
Total adjusted expenses | 583 | 515 | 1,027 | 525 | 522 | 583 | 522 | |||||||||||||||||||||||||||||||||||||
Adjusted earnings before provision for income tax | (90) | 7 | (543) | 2 | (46) | (90) | (46) | |||||||||||||||||||||||||||||||||||||
Provision for income tax expense (benefit) | (20) | 1 | (117) | — | (10) | (20) | (10) | |||||||||||||||||||||||||||||||||||||
Adjusted earnings | $(70) | $6 | $(426) | $2 | $(36) | $(70) | $(36) |
Financial Supplement | 13 |
For the Three Months Ended | ||||||||||||||||||||||||||||||||
UNIVERSAL LIFE WITH SECONDARY GUARANTEES ACCOUNT VALUE | March 31, 2020 | December 31, 2019 | September 30, 2019 | June 30, 2019 | March 31, 2019 | |||||||||||||||||||||||||||
Account value, beginning of period | $6,018 | $6,058 | $6,084 | $6,110 | $6,154 | |||||||||||||||||||||||||||
Premiums and deposits (1) | 180 | 186 | 184 | 191 | 187 | |||||||||||||||||||||||||||
Surrenders and contract benefits | (24) | (34) | (18) | (27) | (39) | |||||||||||||||||||||||||||
Net flows | 156 | 152 | 166 | 164 | 148 | |||||||||||||||||||||||||||
Interest credited | 57 | 59 | 58 | 58 | 57 | |||||||||||||||||||||||||||
Policy charges and other | (252) | (251) | (250) | (248) | (249) | |||||||||||||||||||||||||||
Account value, end of period | $5,979 | $6,018 | $6,058 | $6,084 | $6,110 |
As of | ||||||||||||||||||||||||||||||||
LIFE INSURANCE IN-FORCE | March 31, 2020 | December 31, 2019 | September 30, 2019 | June 30, 2019 | March 31, 2019 | |||||||||||||||||||||||||||
Universal Life with Secondary Guarantees | ||||||||||||||||||||||||||||||||
Life Insurance in-force, before reinsurance | $77,428 | $78,008 | $78,722 | $79,243 | $79,817 | |||||||||||||||||||||||||||
Life Insurance in-force, net of reinsurance | $37,481 | $37,740 | $36,698 | $36,945 | $37,233 | |||||||||||||||||||||||||||
(1) Includes premiums and sales directed to the general account investment option of variable products. |
Financial Supplement | 14 |
For the Three Months Ended | For the Three Months Ended | |||||||||||||||||||||||||||||||||||||||||||
Adjusted revenues | March 31, 2020 | December 31, 2019 | September 30, 2019 | June 30, 2019 | March 31, 2019 | March 31, 2020 | March 31, 2019 | |||||||||||||||||||||||||||||||||||||
Premiums | $22 | $22 | $23 | $22 | $23 | $22 | $23 | |||||||||||||||||||||||||||||||||||||
Universal life and investment-type product policy fees | — | — | — | (2) | (3) | — | (3) | |||||||||||||||||||||||||||||||||||||
Net investment income | 20 | 18 | 23 | 17 | 17 | 20 | 17 | |||||||||||||||||||||||||||||||||||||
Other revenues | — | 4 | 1 | 5 | 6 | — | 6 | |||||||||||||||||||||||||||||||||||||
Total adjusted revenues | $42 | $44 | $47 | $42 | $43 | $42 | $43 | |||||||||||||||||||||||||||||||||||||
Adjusted expenses | ||||||||||||||||||||||||||||||||||||||||||||
Interest credited to policyholder account balances | $— | $— | $— | $— | $— | $— | $— | |||||||||||||||||||||||||||||||||||||
Policyholder benefits and claims | 17 | 14 | 18 | 13 | 14 | 17 | 14 | |||||||||||||||||||||||||||||||||||||
Amortization of DAC and VOBA | 3 | 3 | 3 | 4 | 4 | 3 | 4 | |||||||||||||||||||||||||||||||||||||
Interest expense on debt | 47 | 47 | 49 | 48 | 47 | 47 | 47 | |||||||||||||||||||||||||||||||||||||
Other operating costs | 34 | 57 | 44 | 62 | 50 | 34 | 50 | |||||||||||||||||||||||||||||||||||||
Total adjusted expenses | 101 | 121 | 114 | 127 | 115 | 101 | 115 | |||||||||||||||||||||||||||||||||||||
Adjusted earnings before provision for income tax | (59) | (77) | (67) | (85) | (72) | (59) | (72) | |||||||||||||||||||||||||||||||||||||
Provision for income tax expense (benefit) | (22) | (21) | (57) | (21) | (22) | (22) | (22) | |||||||||||||||||||||||||||||||||||||
Adjusted earnings after provision for income tax | (37) | (56) | (10) | (64) | (50) | (37) | (50) | |||||||||||||||||||||||||||||||||||||
Less: Net income (loss) attributable to noncontrolling interests and preferred stock dividends | 9 | 8 | 9 | 7 | 2 | 9 | 2 | |||||||||||||||||||||||||||||||||||||
Adjusted earnings | $(46) | $(64) | $(19) | $(71) | $(52) | $(46) | $(52) |
Financial Supplement | 16 |
For the Three Months Ended | ||||||||||||||||||||||||||||||||
DAC AND VOBA ROLLFORWARD | March 31, 2020 | December 31, 2019 | September 30, 2019 | June 30, 2019 | March 31, 2019 | |||||||||||||||||||||||||||
Balance, beginning of period | $5,448 | $5,317 | $5,492 | $5,680 | $5,717 | |||||||||||||||||||||||||||
Capitalization | 98 | 95 | 93 | 96 | 86 | |||||||||||||||||||||||||||
Amortization: | ||||||||||||||||||||||||||||||||
Included in adjusted earnings, excluding notable items | (99) | (137) | (162) | (153) | (97) | |||||||||||||||||||||||||||
Related to notable items, included in adjusted expenses | — | 35 | (21) | — | — | |||||||||||||||||||||||||||
Related to items not included in adjusted expenses | (671) | 93 | 2 | (17) | 75 | |||||||||||||||||||||||||||
Total amortization | (770) | (9) | (181) | (170) | (22) | |||||||||||||||||||||||||||
Unrealized investment gains (losses) | 86 | 45 | (87) | (114) | (101) | |||||||||||||||||||||||||||
Balance, end of period | $4,862 | $5,448 | $5,317 | $5,492 | $5,680 | |||||||||||||||||||||||||||
As of | ||||||||||||||||||||||||||||||||
DAC AND VOBA BY SEGMENT AND CORPORATE & OTHER | March 31, 2020 | December 31, 2019 | September 30, 2019 | June 30, 2019 | March 31, 2019 | |||||||||||||||||||||||||||
Annuities | $3,745 | $4,327 | $4,191 | $4,382 | $4,534 | |||||||||||||||||||||||||||
Life | 1,018 | 1,019 | 1,021 | 1,001 | 1,034 | |||||||||||||||||||||||||||
Run-off | 5 | 5 | 5 | 5 | 5 | |||||||||||||||||||||||||||
Corporate & Other | 94 | 97 | 100 | 104 | 107 | |||||||||||||||||||||||||||
Total DAC and VOBA | $4,862 | $5,448 | $5,317 | $5,492 | $5,680 |
For the Three Months Ended | ||||||||||||||||||||||||||||||||
NET DERIVATIVE GAINS (LOSSES) | March 31, 2020 | December 31, 2019 | September 30, 2019 | June 30, 2019 | March 31, 2019 | |||||||||||||||||||||||||||
Net derivative gains (losses): | ||||||||||||||||||||||||||||||||
Variable annuity hedges and embedded derivatives, net | $5,181 | $(1,419) | $418 | $(194) | $(1,439) | |||||||||||||||||||||||||||
ULSG hedges | 1,583 | (446) | 656 | 312 | 122 | |||||||||||||||||||||||||||
Other hedges and embedded derivatives | 134 | (32) | (17) | 31 | 14 | |||||||||||||||||||||||||||
Subtotal | 6,898 | (1,897) | 1,057 | 149 | (1,303) | |||||||||||||||||||||||||||
Investment hedge adjustments | 4 | 6 | — | — | — | |||||||||||||||||||||||||||
Total net derivative gains (losses) | $6,902 | $(1,891) | $1,057 | $149 | $(1,303) |
Financial Supplement | 17 |
For the Three Months Ended | ||||||||||||||||||||||||||||||||
NOTABLE ITEMS IMPACTING ADJUSTED EARNINGS | March 31, 2020 | December 31, 2019 | September 30, 2019 | June 30, 2019 | March 31, 2019 | |||||||||||||||||||||||||||
Actuarial items and other insurance adjustments | $48 | $(42) | $442 | $12 | $— | |||||||||||||||||||||||||||
Establishment costs | 14 | 25 | 10 | 30 | 27 | |||||||||||||||||||||||||||
Separation-related transactions | — | — | (23) | — | — | |||||||||||||||||||||||||||
Total notable items (1) | $62 | $(17) | $429 | $42 | $27 | |||||||||||||||||||||||||||
NOTABLE ITEMS BY SEGMENT AND CORPORATE & OTHER | ||||||||||||||||||||||||||||||||
Annuities | $— | $(42) | $30 | $— | $— | |||||||||||||||||||||||||||
Life | — | — | (19) | — | — | |||||||||||||||||||||||||||
Run-off | 48 | — | 431 | 12 | — | |||||||||||||||||||||||||||
Corporate & Other | 14 | 25 | (13) | 30 | 27 | |||||||||||||||||||||||||||
Total notable items (1) | $62 | $(17) | $429 | $42 | $27 | |||||||||||||||||||||||||||
(1) Notable items reflect the negative (positive) after-tax impact to adjusted earnings of certain unanticipated items and events, as well as certain items and events that were anticipated, such as establishment costs. The presentation of notable items is intended to help investors better understand our results and to evaluate and forecast those results. |
Financial Supplement | 18 |
For the Three Months Ended | ||||||||||||||||||||||||||||||||
VARIABLE ANNUITY SEPARATE ACCOUNT RETURNS | March 31, 2020 | December 31, 2019 | September 30, 2019 | June 30, 2019 | March 31, 2019 | |||||||||||||||||||||||||||
Total Quarterly VA separate account gross returns | (14.31)% | 6.14% | 0.83% | 3.84% | 10.02% | |||||||||||||||||||||||||||
TOTAL VARIABLE ANNUITY SEPARATE ACCOUNT ALLOCATIONS | ||||||||||||||||||||||||||||||||
Percent allocated to equity funds | 24.11% | 26.19% | 25.52% | 25.04% | 25.72% | |||||||||||||||||||||||||||
Percent allocated to bond funds/other funds | 9.59% | 8.23% | 8.50% | 8.23% | 8.30% | |||||||||||||||||||||||||||
Percent allocated to target volatility funds | 24.41% | 23.10% | 23.51% | 24.11% | 22.97% | |||||||||||||||||||||||||||
Percent allocated to balanced funds | 41.89% | 42.48% | 42.47% | 42.62% | 43.01% | |||||||||||||||||||||||||||
Financial Supplement | 19 |
March 31, 2020 | December 31, 2019 | |||||||||||||||||||||||||
Amount | % of Total | Amount | % of Total | |||||||||||||||||||||||
Fixed maturity securities: | ||||||||||||||||||||||||||
U.S. corporate securities | $30,670 | 26.98% | $31,160 | 31.58% | ||||||||||||||||||||||
Foreign corporate securities | 9,244 | 8.13% | 9,844 | 9.98% | ||||||||||||||||||||||
Residential mortgage-backed securities | 8,900 | 7.83% | 9,118 | 9.24% | ||||||||||||||||||||||
U.S. government and agency securities | 8,926 | 7.85% | 7,396 | 7.50% | ||||||||||||||||||||||
Commercial mortgage-backed securities | 5,745 | 5.06% | 5,755 | 5.83% | ||||||||||||||||||||||
State and political subdivision securities | 4,143 | 3.65% | 4,057 | 4.11% | ||||||||||||||||||||||
Asset-backed securities | 2,027 | 1.78% | 1,955 | 1.98% | ||||||||||||||||||||||
Foreign government securities | 1,647 | 1.45% | 1,751 | 1.78% | ||||||||||||||||||||||
Total fixed maturity securities | 71,302 | 62.73% | 71,036 | 72.00% | ||||||||||||||||||||||
Equity securities | 122 | 0.11% | 147 | 0.15% | ||||||||||||||||||||||
Mortgage loans: | ||||||||||||||||||||||||||
Commercial mortgage loans | 9,512 | 8.37% | 9,721 | 9.85% | ||||||||||||||||||||||
Agricultural mortgage loans | 3,403 | 2.99% | 3,388 | 3.44% | ||||||||||||||||||||||
Residential mortgage loans | 2,701 | 2.38% | 2,708 | 2.74% | ||||||||||||||||||||||
Allowance for credit losses | (69) | (0.06)% | (64) | (0.06)% | ||||||||||||||||||||||
Total mortgage loans, net | 15,547 | 13.68% | 15,753 | 15.97% | ||||||||||||||||||||||
Policy loans | 1,250 | 1.10% | 1,292 | 1.31% | ||||||||||||||||||||||
Limited partnerships and limited liability companies | 2,505 | 2.20% | 2,380 | 2.41% | ||||||||||||||||||||||
Cash, cash equivalents and short-term investments | 13,278 | 11.68% | 4,835 | 4.90% | ||||||||||||||||||||||
Other invested assets: | ||||||||||||||||||||||||||
Derivatives: | ||||||||||||||||||||||||||
Interest rate | 5,950 | 5.23% | 1,778 | 1.80% | ||||||||||||||||||||||
Equity market | 2,677 | 2.35% | 921 | 0.93% | ||||||||||||||||||||||
Foreign currency exchange rate | 850 | 0.75% | 286 | 0.29% | ||||||||||||||||||||||
Credit | 7 | 0.01% | 36 | 0.04% | ||||||||||||||||||||||
Total derivatives | 9,484 | 8.34% | 3,021 | 3.06% | ||||||||||||||||||||||
FHLB common stock | 39 | 0.04% | 39 | 0.04% | ||||||||||||||||||||||
Other | 135 | 0.12% | 156 | 0.16% | ||||||||||||||||||||||
Total other invested assets | 9,658 | 8.50% | 3,216 | 3.26% | ||||||||||||||||||||||
Total investments and cash and cash equivalents | $113,662 | 100.00% | $98,659 | 100.00% |
For the Three Months Ended | ||||||||||||||||||||||||||||||||
March 31, 2020 | December 31, 2019 | September 30, 2019 | June 30, 2019 | March 31, 2019 | ||||||||||||||||||||||||||||
Net investment income yield (1), (2) | 4.30% | 4.32% | 4.52% | 4.67% | 4.10% | |||||||||||||||||||||||||||
(1) Yields are calculated on investment income as a percent of average quarterly asset carrying values. Investment income includes investment hedge adjustments, excludes realized gains and losses and reflects the GAAP adjustments described beginning on page A-1 of the Appendix hereto. Asset carrying values exclude unrealized gains (losses), collateral received in connection with our securities lending program, freestanding derivative assets and collateral received from derivative counterparties. | ||||||||||||||||||||||||||||||||
(2) Investment fee and expense yields are calculated as investment fees and expenses as a percent of average quarterly asset estimated fair values. Asset estimated fair values exclude collateral received in connection with our securities lending program, freestanding derivative assets and collateral received from derivative counterparties. |
Financial Supplement | 20 |
For the Three Months Ended | For the Three Months Ended | |||||||||||||||||||||||||||||||||||||||||||
COMBINED REVENUES AND EXPENSES (1) | PRELIMINARY March 31, 2020 (2) | December 31, 2019 | September 30, 2019 | June 30, 2019 | March 31, 2019 | PRELIMINARY March 31, 2020 (2) | March 31, 2019 | |||||||||||||||||||||||||||||||||||||
Total revenues (Line 9) | $5,700 | $2,086 | $3,443 | $3,436 | $2,393 | $5,700 | $2,393 | |||||||||||||||||||||||||||||||||||||
Total benefits and expenses before dividends to policyholders (Line 28) | $13,000 | $1,008 | $3,047 | $2,839 | $2,429 | $13,000 | $2,429 | |||||||||||||||||||||||||||||||||||||
COMBINED NET INCOME (LOSS) (1) | ||||||||||||||||||||||||||||||||||||||||||||
Gain (loss) from operations net of taxes and dividends to policyholders (Line 33) | $(7,300) | $1,089 | $314 | $597 | $(43) | $(7,300) | $(43) | |||||||||||||||||||||||||||||||||||||
Net realized capital gains (losses), net of taxes and certain transfers to interest maintenance reserve (Line 34) | 500 | (297) | 185 | (701) | (147) | 500 | (147) | |||||||||||||||||||||||||||||||||||||
Net income (loss) (Line 35) | $(6,800) | $792 | $499 | $(104) | $(190) | $(6,800) | $(190) | |||||||||||||||||||||||||||||||||||||
For the Three Months Ended | ||||||||||||||||||||||||||||||||||||||||||||
NORMALIZED STATUTORY EARNINGS (LOSS) (3), (4) | PRELIMINARY March 31, 2020 (2) | March 31, 2019 | ||||||||||||||||||||||||||||||||||||||||||
(In billions) | ||||||||||||||||||||||||||||||||||||||||||||
Statutory net gain (loss) from operations, pre-tax | $(7.4) | $— | ||||||||||||||||||||||||||||||||||||||||||
Add: net realized capital gains (losses) | 0.5 | (0.1) | ||||||||||||||||||||||||||||||||||||||||||
Add: change in CTE95 capital requirements, net of the change in VA reserves | 1.1 | 1.6 | ||||||||||||||||||||||||||||||||||||||||||
Add: unrealized gains (losses) on VA hedging program | 5.0 | (1.2) | ||||||||||||||||||||||||||||||||||||||||||
Normalized statutory earnings (loss) | $(0.8) | $0.3 | ||||||||||||||||||||||||||||||||||||||||||
(1) Combined statutory results are for Brighthouse Life Insurance Company, Brighthouse Life Insurance Company of NY and New England Life Insurance Company. | ||||||||||||||||||||||||||||||||||||||||||||
(2) Reflects preliminary statutory results for the three months ended March 31, 2020. | ||||||||||||||||||||||||||||||||||||||||||||
(3) See definitions for Non-GAAP and Other Financial Disclosures in the Appendix beginning on page A-2. | ||||||||||||||||||||||||||||||||||||||||||||
(4) Normalized statutory earnings (loss), presented in billions, is for Brighthouse Life Insurance Company and New England Life Insurance Company. |
Financial Supplement | 21 |
As of | |||||||||||||||||||||||||||||||||||
COMBINED ASSETS, LIABILITIES, AND CAPITAL AND SURPLUS (1) | PRELIMINARY March 31, 2020 (2) | December 31, 2019 | September 30, 2019 | June 30, 2019 | March 31, 2019 | ||||||||||||||||||||||||||||||
Total assets (Line 28) | $185,000 | $186,564 | $185,743 | $181,989 | $178,745 | ||||||||||||||||||||||||||||||
Total liabilities (Line 28) | $178,700 | $177,702 | $178,103 | $175,788 | $172,788 | ||||||||||||||||||||||||||||||
Total capital and surplus (Line 38) | $6,300 | $8,862 | $7,640 | $6,201 | $5,957 | ||||||||||||||||||||||||||||||
COMBINED TAC AND RBC RATIO (1), (3) | |||||||||||||||||||||||||||||||||||
Combined total adjusted capital | $7,200 | $9,694 | $8,406 | $6,897 | $6,314 | ||||||||||||||||||||||||||||||
Combined risk-based capital ratio (4) | 515% - 535% | 552% | N/A | N/A | N/A | ||||||||||||||||||||||||||||||
As of | |||||||||||||||||||||||||||||||||||
COMBINED ORDINARY DIVIDEND CAPACITY (1) | March 31, 2020 | December 31, 2019 | September 30, 2019 | June 30, 2019 | March 31, 2019 | ||||||||||||||||||||||||||||||
Dividends paid to Holding Company | $300 | $131 | $— | $— | $— | ||||||||||||||||||||||||||||||
Remaining ordinary dividend capacity (5) | $1,827 | $798 | $929 | $929 | $929 | ||||||||||||||||||||||||||||||
(1) Combined statutory results are for Brighthouse Life Insurance Company and New England Life Insurance Company. | |||||||||||||||||||||||||||||||||||
(2) Reflects preliminary statutory results as of March 31, 2020. | |||||||||||||||||||||||||||||||||||
(3) See definitions for Non-GAAP and Other Financial Disclosures in the Appendix beginning on page A-2. | |||||||||||||||||||||||||||||||||||
(4) RBC ratios prior to the implementation of variable annuity capital reform are not presented. | |||||||||||||||||||||||||||||||||||
(5) Reflects remaining dividend amounts that may be paid during the respective calendar year without prior regulatory approval. However, because dividend tests may be based on dividends previously paid over rolling 12-month periods, if paid before a specified date during such calendar year, some or all of such dividends may require regulatory approval. |
Financial Supplement | A-1 |
Financial Supplement | A-2 |
Non-GAAP financial measures: | Most directly comparable GAAP financial measures: | |||||||||||||
(i) | adjusted earnings | (i) | net income (loss) available to shareholders (1) | |||||||||||
(ii) | adjusted earnings, less notable items | (ii) | net income (loss) available to shareholders (1) | |||||||||||
(iii) | adjusted revenues | (iii) | revenues | |||||||||||
(iv) | adjusted expenses | (iv) | expenses | |||||||||||
(v) | adjusted earnings per common share | (v) | earnings per common share, diluted (1) | |||||||||||
(vi) | adjusted earnings per common share, less notable items | (vi) | earnings per common share, diluted (1) | |||||||||||
(vii) | adjusted return on common equity | (vii) | return on common equity (2) | |||||||||||
(viii) | adjusted return on common equity, less notable items | (viii) | return on common equity (2) | |||||||||||
(ix) | adjusted net investment income | (ix) | net investment income | |||||||||||
__________________ | ||||||||||||||
(1) Brighthouse uses net income (loss) available to shareholders to refer to net income (loss) available to Brighthouse Financial, Inc.'s common shareholders, and earnings per common share, diluted to refer to net income (loss) available to shareholders per common share. | ||||||||||||||
(2) Brighthouse uses return on common equity to refer to return on Brighthouse Financial, Inc.'s common stockholders' equity. |
Financial Supplement | A-3 |
Financial Supplement | A-4 |
Financial Supplement | A-5 |
Financial Supplement | A-6 |
AOCI | Accumulated other comprehensive income (loss) | ||||
CTE | Conditional tail expectations | ||||
DAC | Deferred policy acquisition costs | ||||
FHLB | Federal Home Loan Bank | ||||
GAAP | Accounting principles generally accepted in the United States of America | ||||
GMAB | Guaranteed minimum accumulation benefits | ||||
GMDB | Guaranteed minimum death benefits | ||||
GMIB | Guaranteed minimum income benefits | ||||
GMWB | Guaranteed minimum withdrawal benefits | ||||
LIMRA | Life Insurance Marketing and Research Association | ||||
NDGL | Net derivative gains (losses) | ||||
NIGL | Net investment gains (losses) | ||||
RBC | Risk-based capital | ||||
TAC | Total adjusted capital | ||||
ULSG | Universal life insurance with secondary guarantees | ||||
VA | Variable annuity | ||||
VOBA | Value of business acquired |
Financial Supplement | A-7 |
For the Three Months Ended | ||||||||||||||||||||||||||||||||
ADJUSTED EARNINGS, LESS NOTABLE ITEMS | March 31, 2020 | December 31, 2019 | September 30, 2019 | June 30, 2019 | March 31, 2019 | |||||||||||||||||||||||||||
Net income (loss) available to shareholders | $4,950 | $(1,077) | $676 | $377 | $(737) | |||||||||||||||||||||||||||
Less: Net investment gains (losses) | (19) | 33 | 27 | 63 | (11) | |||||||||||||||||||||||||||
Less: Net derivative gains (losses), excluding investment hedge adjustments | 6,898 | (1,897) | 1,057 | 149 | (1,303) | |||||||||||||||||||||||||||
Less: GMIB Fees and GMIB Costs | (166) | 34 | (4) | (22) | 35 | |||||||||||||||||||||||||||
Less: Amortization of DAC and VOBA | (671) | 93 | 2 | (17) | 75 | |||||||||||||||||||||||||||
Less: Market value adjustments and other | (43) | 17 | (14) | (16) | (23) | |||||||||||||||||||||||||||
Less: Provision for income tax (expense) benefit on reconciling adjustments | (1,260) | 361 | (223) | (34) | 258 | |||||||||||||||||||||||||||
Adjusted earnings | 211 | 282 | (169) | 254 | 232 | |||||||||||||||||||||||||||
Less: Notable items | (62) | 17 | (429) | (42) | (27) | |||||||||||||||||||||||||||
Adjusted earnings, less notable items | $273 | $265 | $260 | $296 | $259 | |||||||||||||||||||||||||||
ADJUSTED EARNINGS, LESS NOTABLE ITEMS PER COMMON SHARE (1), (2) | ||||||||||||||||||||||||||||||||
Net income (loss) available to shareholders per common share | $47.11 | $(10.02) | $6.06 | $3.27 | $(6.31) | |||||||||||||||||||||||||||
Less: Net investment gains (losses) | (0.18) | 0.31 | 0.24 | 0.55 | (0.09) | |||||||||||||||||||||||||||
Less: Net derivative gains (losses), excluding investment hedge adjustments | 65.64 | (17.65) | 9.48 | 1.29 | (11.16) | |||||||||||||||||||||||||||
Less: GMIB Fees and GMIB Costs | (1.58) | 0.32 | (0.04) | (0.19) | 0.30 | |||||||||||||||||||||||||||
Less: Amortization of DAC and VOBA | (6.38) | 0.87 | 0.02 | (0.15) | 0.64 | |||||||||||||||||||||||||||
Less: Market value adjustments and other | (0.41) | 0.16 | (0.13) | (0.14) | (0.20) | |||||||||||||||||||||||||||
Less: Provision for income tax (expense) benefit on reconciling adjustments | (11.99) | 3.36 | (2.00) | (0.29) | 2.21 | |||||||||||||||||||||||||||
Less: Impact of inclusion of dilutive shares | — | 0.01 | — | — | 0.01 | |||||||||||||||||||||||||||
Adjusted earnings per common share | 2.01 | 2.61 | (1.52) | 2.19 | 1.98 | |||||||||||||||||||||||||||
Less: Notable items | (0.59) | 0.16 | (3.85) | (0.36) | (0.23) | |||||||||||||||||||||||||||
Adjusted earnings, less notable items per common share | $2.60 | $2.46 | $2.33 | $2.56 | $2.21 | |||||||||||||||||||||||||||
(1) See definitions for Non-GAAP and Other Financial Disclosures in this Appendix. | ||||||||||||||||||||||||||||||||
(2) Per share calculations are on a diluted basis and may not recalculate or foot due to rounding. For loss periods, dilutive shares were not included in the calculation as inclusion of such shares would have an anti-dilutive effect. |
Financial Supplement | A-8 |
Four Quarters Cumulative Trailing Basis | ||||||||||||||||||||||||||||||||
ADJUSTED EARNINGS | March 31, 2020 | December 31, 2019 | September 30, 2019 | June 30, 2019 | March 31, 2019 | |||||||||||||||||||||||||||
Net income (loss) available to shareholders | $4,926 | $(761) | $1,758 | $811 | $195 | |||||||||||||||||||||||||||
Less: Net investment gains (losses) | 104 | 112 | (7) | (76) | (214) | |||||||||||||||||||||||||||
Less: Net derivative gains (losses), excluding investment hedge adjustments | 6,207 | (1,994) | 1,941 | 191 | (274) | |||||||||||||||||||||||||||
Less: GMIB Fees and GMIB Costs | (158) | 43 | (128) | (96) | (93) | |||||||||||||||||||||||||||
Less: Amortization of DAC and VOBA | (593) | 153 | (173) | (153) | (232) | |||||||||||||||||||||||||||
Less: Market value adjustments and other | (56) | (36) | (54) | (37) | (12) | |||||||||||||||||||||||||||
Less: Provision for income tax (expense) benefit on reconciling adjustments | (1,156) | 362 | (324) | 40 | 179 | |||||||||||||||||||||||||||
Adjusted earnings | $578 | $599 | $503 | $942 | $841 | |||||||||||||||||||||||||||
Five Quarters Average Stockholders' Equity Basis | ||||||||||||||||||||||||||||||||
BRIGHTHOUSE FINANCIAL, INC.’S COMMON STOCKHOLDERS’ EQUITY, EXCLUDING AOCI | March 31, 2020 | December 31, 2019 | September 30, 2019 | June 30, 2019 | March 31, 2019 | |||||||||||||||||||||||||||
Brighthouse Financial, Inc.’s stockholders’ equity | $17,103 | $15,912 | $15,254 | $14,402 | $13,864 | |||||||||||||||||||||||||||
Less: Preferred stock, net | 412 | 330 | 247 | 165 | 82 | |||||||||||||||||||||||||||
Brighthouse Financial, Inc.’s common stockholders’ equity | 16,691 | 15,582 | 15,007 | 14,237 | 13,782 | |||||||||||||||||||||||||||
Less: AOCI | 2,765 | 2,379 | 1,841 | 1,291 | 898 | |||||||||||||||||||||||||||
Brighthouse Financial, Inc.’s common stockholders’ equity, excluding AOCI | $13,926 | $13,203 | $13,166 | $12,946 | $12,884 | |||||||||||||||||||||||||||
Five Quarters Average Common Stockholders' Equity Basis | ||||||||||||||||||||||||||||||||
ADJUSTED RETURN ON COMMON EQUITY | March 31, 2020 | December 31, 2019 | September 30, 2019 | June 30, 2019 | March 31, 2019 | |||||||||||||||||||||||||||
Return on common equity | 29.5% | (4.9)% | 11.7% | 5.7% | 1.4% | |||||||||||||||||||||||||||
Return on AOCI | 178.2% | (32.0)% | 95.5% | 62.8% | 21.7% | |||||||||||||||||||||||||||
Return on common equity, excluding AOCI | 35.4% | (5.8)% | 13.4% | 6.3% | 1.5% | |||||||||||||||||||||||||||
Less: Return on net investment gains (losses) | 0.7% | 0.8% | —% | (0.6)% | (1.7)% | |||||||||||||||||||||||||||
Less: Return on net derivative gains (losses), excluding investment hedge adjustments | 44.6% | (15.1)% | 14.7% | 1.5% | (2.1)% | |||||||||||||||||||||||||||
Less: Return on GMIB Fees and GMIB Costs | (1.1)% | 0.3% | (0.9)% | (0.7)% | (0.7)% | |||||||||||||||||||||||||||
Less: Return on amortization of DAC and VOBA | (4.3)% | 1.2% | (1.3)% | (1.2)% | (1.8)% | |||||||||||||||||||||||||||
Less: Return on market value adjustments and other | (0.4)% | (0.2)% | (0.4)% | (0.3)% | (0.1)% | |||||||||||||||||||||||||||
Less: Return on provision for income tax (expense) benefit on reconciling adjustments | (8.3)% | 2.7% | (2.5)% | 0.3% | 1.4% | |||||||||||||||||||||||||||
Adjusted return on common equity | 4.2% | 4.5% | 3.8% | 7.3% | 6.5% |
Financial Supplement | A-9 |
For the Three Months Ended | For the Three Months Ended | |||||||||||||||||||||||||||||||||||||||||||
March 31, 2020 | December 31, 2019 | September 30, 2019 | June 30, 2019 | March 31, 2019 | March 31, 2020 | March 31, 2019 | ||||||||||||||||||||||||||||||||||||||
Total revenues | $8,985 | $306 | $3,187 | $2,370 | $691 | $8,985 | $691 | |||||||||||||||||||||||||||||||||||||
Less: Net investment gains (losses) | (19) | 33 | 27 | 63 | (11) | (19) | (11) | |||||||||||||||||||||||||||||||||||||
Less: Net derivative gains (losses) | 6,902 | (1,891) | 1,057 | 149 | (1,303) | 6,902 | (1,303) | |||||||||||||||||||||||||||||||||||||
Less: GMIB Fees | 65 | 66 | 67 | 65 | 66 | 65 | 66 | |||||||||||||||||||||||||||||||||||||
Less: Investment hedge adjustments | (4) | (6) | — | — | — | (4) | — | |||||||||||||||||||||||||||||||||||||
Less: Other | 1 | 10 | 1 | — | — | 1 | — | |||||||||||||||||||||||||||||||||||||
Total adjusted revenues | $2,040 | $2,094 | $2,035 | $2,093 | $1,939 | $2,040 | $1,939 | |||||||||||||||||||||||||||||||||||||
Total expenses | $2,733 | $1,678 | $2,383 | $1,901 | $1,644 | $2,733 | $1,644 | |||||||||||||||||||||||||||||||||||||
Less: Amortization of DAC and VOBA | 671 | (93) | (2) | 17 | (75) | 671 | (75) | |||||||||||||||||||||||||||||||||||||
Less: GMIB Costs | 231 | 32 | 71 | 87 | 31 | 231 | 31 | |||||||||||||||||||||||||||||||||||||
Less: Other | 44 | (7) | 15 | 16 | 23 | 44 | 23 | |||||||||||||||||||||||||||||||||||||
Total adjusted expenses | $1,787 | $1,746 | $2,299 | $1,781 | $1,665 | $1,787 | $1,665 |
Financial Supplement | A-10 |
For the Three Months Ended | For the Three Months Ended | |||||||||||||||||||||||||||||||||||||||||||
NET INVESTMENT GAINS (LOSSES) | March 31, 2020 | December 31, 2019 | September 30, 2019 | June 30, 2019 | March 31, 2019 | March 31, 2020 | March 31, 2019 | |||||||||||||||||||||||||||||||||||||
Investment portfolio gains (losses) | $2 | $43 | $30 | $68 | $(8) | $2 | $(8) | |||||||||||||||||||||||||||||||||||||
Investment portfolio writedowns | (21) | (10) | (3) | (5) | (3) | (21) | (3) | |||||||||||||||||||||||||||||||||||||
Total net investment portfolio gains (losses) | (19) | 33 | 27 | 63 | (11) | (19) | (11) | |||||||||||||||||||||||||||||||||||||
Other incremental net investment income | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||
Net investment gains (losses) | $(19) | $33 | $27 | $63 | $(11) | $(19) | $(11) |
For the Three Months Ended | ||||||||||||||||||||||||||||||||
NET INVESTMENT INCOME YIELD | March 31, 2020 | December 31, 2019 | September 30, 2019 | June 30, 2019 | March 31, 2019 | |||||||||||||||||||||||||||
Investment income yield (1) | 4.44% | 4.43% | 4.62% | 4.79% | 4.24% | |||||||||||||||||||||||||||
Investment fees and expenses (2) | (0.14)% | (0.11)% | (0.10)% | (0.12)% | (0.14)% | |||||||||||||||||||||||||||
Net investment income yield | 4.30% | 4.32% | 4.52% | 4.67% | 4.10% | |||||||||||||||||||||||||||
(1) Yields are calculated on investment income as a percent of average quarterly asset carrying values. Investment income includes investment hedge adjustments, excludes realized gains and losses and reflects the GAAP adjustments described beginning on page A-1 of this Appendix. Asset carrying values exclude unrealized gains (losses), collateral received in connection with our securities lending program, freestanding derivative assets and collateral received from derivative counterparties. | ||||||||||||||||||||||||||||||||
(2) Investment fee and expense yields are calculated as investment fees and expenses as a percent of average quarterly asset estimated fair values. Asset estimated fair values exclude collateral received in connection with our securities lending program, freestanding derivative assets and collateral received from derivative counterparties. |